Literature DB >> 32019761

Screening for Cancer in Patients with Glomerular Diseases.

Emmanuelle Plaisier1,2,3,4,5, Pierre Ronco6,7,8,9,10.   

Abstract

Entities:  

Keywords:  Cancer; cost-benefit analysis; cytosolic phospholipases A2; early detection of cancer; follow-up studies; human PLA2R1 protein; humans; immunosuppressive agents; kidney; membranoproliferative glomerulonephritis; membranous nephropathy; neoplasms; nephrologists; nephrology; nephrotic syndrome; phospholipase A2 receptors; phospholipases A2; recurrence; risk factors; thrombospondins; treatment failure

Year:  2020        PMID： 32019761      PMCID： PMC7274290          DOI： 10.2215/CJN.09000819

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

Authors:  C Lefaucheur; B Stengel; D Nochy; P Martel; G S Hill; C Jacquot; J Rossert
Journal:  Kidney Int       Date:  2006-08-30       Impact factor: 10.612

2.  Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.

Authors:  Sjoerd A M E G Timmermans; Rivka Ayalon; Pieter van Paassen; Laurence H Beck; Henk van Rie; Joris J J M Wirtz; Gaico H Verseput; Leon A Frenken; David J Salant; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2013-09-08       Impact factor: 8.860

3.  A Mechanism for Cancer-Associated Membranous Nephropathy.

Authors:  Elion Hoxha; Thorsten Wiech; Phillip R Stahl; Gunther Zahner; Nicola M Tomas; Catherine Meyer-Schwesinger; Ulrich Wenzel; Matthias Janneck; Oliver M Steinmetz; Ulf Panzer; Sigrid Harendza; Rolf A K Stahl
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

Review 4.  Whole-Body 18F-FDG PET and 18F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Authors:  Sara Sheikhbahaei; Charles V Marcus; Roberto S Fragomeni; Steven P Rowe; Mehrbod S Javadi; Lilja B Solnes
Journal:  J Nucl Med       Date:  2016-12-15       Impact factor: 10.057

Review 5.  A Proposal for a Serology-Based Approach to Membranous Nephropathy.

Authors:  An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 10.121

6.  Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.

Authors:  Christelle Zaghrini; Barbara Seitz-Polski; Joana Justino; Guillaume Dolla; Christine Payré; Noémie Jourde-Chiche; Anne-Els Van de Logt; Caroline Booth; Emma Rigby; Jennie Lonnbro-Widgren; Jenny Nystrom; Christophe Mariat; Zhao Cui; Jack F M Wetzels; GianMarco Ghiggeri; Laurence H Beck; Pierre Ronco; Hanna Debiec; Gérard Lambeau
Journal:  Kidney Int       Date:  2019-03       Impact factor: 10.612

Review 7.  Onco-nephrology: glomerular diseases with cancer.

Authors:  Jean-François Cambier; Pierre Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 8.237

8.  Long-term risk of cancer in membranous nephropathy patients.

Authors:  Rune Bjørneklett; Bjørn Egil Vikse; Einar Svarstad; Knut Aasarød; Leif Bostad; Frøydis Langmark; Bjarne M Iversen
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

9.  Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.

Authors:  Jia Wang; Zhao Cui; Jie Lu; Christian Probst; Yi-Miao Zhang; Xin Wang; Zhen Qu; Fang Wang; Li-Qiang Meng; Xu-Yang Cheng; Gang Liu; Hanna Debiec; Pierre Ronco; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-11       Impact factor: 8.237

10.  A follow-up analysis of positron emission tomography/computed tomography in detecting hidden malignancies at the time of diagnosis of membranous nephropathy.

Authors:  Zhonglin Feng; Shuxia Wang; Yanlin Huang; Xinling Liang; Wei Shi; Bin Zhang
Journal:  Oncotarget       Date:  2016-03-01
  10 in total
  12 in total

1.  Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: Pro.

Authors:  Jonathan J Hogan
Journal:  Kidney360       Date:  2020-07-13

Review 2.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

3.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

Review 4.  Advances in Membranous Nephropathy.

Authors:  Pierre Ronco; Emmanuelle Plaisier; Hanna Debiec
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

Review 5.  Membranous nephropathy: current understanding of various causes in light of new target antigens.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-05-01       Impact factor: 3.416

Review 6.  Rituximab in Membranous Nephropathy.

Authors:  Philipp Gauckler; Jae Il Shin; Federico Alberici; Vincent Audard; Annette Bruchfeld; Martin Busch; Chee Kay Cheung; Matija Crnogorac; Elisa Delbarba; Kathrin Eller; Stanislas Faguer; Kresimir Galesic; Siân Griffin; Martijn W F van den Hoogen; Zdenka Hrušková; Anushya Jeyabalan; Alexandre Karras; Catherine King; Harbir Singh Kohli; Gert Mayer; Rutger Maas; Masahiro Muto; Sergey Moiseev; Balazs Odler; Ruth J Pepper; Luis F Quintana; Jai Radhakrishnan; Raja Ramachandran; Alan D Salama; Ulf Schönermarck; Mårten Segelmark; Lee Smith; Vladimír Tesař; Jack Wetzels; Lisa Willcocks; Martin Windpessl; Ladan Zand; Reza Zonozi; Andreas Kronbichler
Journal:  Kidney Int Rep       Date:  2021-01-13

7.  Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection.

Authors:  Lyle W Baker; Jaime Jimenez-Lopez; Xochiquetzal J Geiger; Nabeel Aslam
Journal:  Case Rep Nephrol Dial       Date:  2021-11-18

Review 8.  How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.

Authors:  Tiffany N Caza; Laith F Al-Rabadi; Laurence H Beck
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

9.  A Diverse Spectrum of Immune Complex- and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma.

Authors:  Nicole K Andeen; Shahad Abdulameer; Vivek Charu; Jonathan E Zuckerman; Megan Troxell; Neeraja Kambham; Charles E Alpers; Behzad Najafian; Roberto F Nicosia; Kelly D Smith; Vanderlene L Kung; Rupali S Avasare; Anusha Vallurupalli; J Ashley Jefferson; Douglas Hecox; Leah Swetnam; Michifumi Yamashita; Mercury Lin; Mei Lin Bissonnette; Shreeram Akilesh; Jean Hou
Journal:  Kidney Int Rep       Date:  2021-12-27

10.  Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab.

Authors:  Jamie S Lin; Daniel Y Wang; Omar Mamlouk; William F Glass; Maen Abdelrahim; Cassian Yee; Ala Abudayyeh
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.